Arvinas Inc
Arvinas Inc (ARVN) Options Open Interest
ARVN options open interest is 5,194 contracts. The 2-week average daily volume is 241 contracts across the chain.
Read more
Monitoring ARVN open interest helps you see where real money is positioned on Arvinas Inc's options and which strikes are attracting the most commitment from traders. Arvinas Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ARVN options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ARVN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Arvinas Inc to settle.
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC.
The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ARVN open interest is concentrated. Our scanner maps Arvinas Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Arvinas Inc's options open interest as the signal it is, not as an afterthought.
| 8.00 | 0.30 | 1.10 | 0.70 | 45% | +0.7320 | 709 |
| 10.00 | 0.05 | 0.15 | 0.10 | 58% | +0.1603 | 262 |
| 9.00 | — | 0.55 | 0.55 | 86% | +0.4463 | 132 |
| 12.00 | — | 0.75 | 0.75 | 199% | +0.3371 | 106 |
| 11.00 | — | 0.75 | 0.75 | 175% | +0.3637 | 81 |
| 10.00 | 1.15 | 2.05 | 1.60 | 65% | -0.8104 | 103 |
| 8.00 | 0.10 | 0.55 | 0.33 | 66% | -0.3198 | 85 |
| 9.00 | 0.25 | 2.80 | 1.53 | 145% | -0.4843 | 63 |
| 7.00 | — | 0.25 | 0.25 | 101% | -0.1845 | 15 |
| 11.00 | 2.10 | 3.20 | 2.65 | 97% | -0.8167 | 1 |
As of September 23, 2026
Follow the money
Track ARVN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→